BARCLAYS PLC - HALOZYME THERAPEUTICS INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,137
+8.0%
1,341,000
+6.1%
0.00%0.0%
Q2 2023$1,053
+8675.0%
1,264,000
+10433.3%
0.00%
Q4 2022$12
-100.0%
12,000
-87.1%
0.00%
Q3 2022$79,000
+1875.0%
93,000
+1760.0%
0.00%
Q1 2022$4,0005,0000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Wellesley Asset Management 70,776,482$60,420,9114.46%
Lombard Odier Asset Management (Europe) Ltd 41,798,000$35,110,3201.74%
CAMDEN ASSET MANAGEMENT L P /CA 47,123,000$39,937,0731.34%
Penn Mutual Asset Management 1,555,000$1,318,1971.25%
DAVIDSON KEMPNER PARTNERS 66,537,000$56,390,5731.09%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 66,537,000$56,390,5730.96%
ZAZOVE ASSOCIATES LLC 9,443,000$8,0110.73%
SHENKMAN CAPITAL MANAGEMENT INC 8,934,000$7,582,4300.58%
CSS LLC/IL 8,000,000$6,788,2880.45%
READYSTATE ASSET MANAGEMENT LP 5,000,000$4,262,5340.40%
View complete list of HALOZYME THERAPEUTICS INC shareholders